Page last updated: 2024-12-11

oleoyl-estrone

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

oleoyl-estrone: induces the loss of body fat in rats [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID6918373
SCHEMBL ID38079
MeSH IDM0282366

Synonyms (18)

Synonym
oleoyl-estrone
estrone 3-oleate
[(8r,9s,13s,14s)-13-methyl-17-oxo-7,8,9,11,12,14,15,16-octahydro-6h-cyclopenta[a]phenanthren-3-yl] (z)-octadec-9-enoate
merlin-2
oleoyl estrone
estra-1,3,5(10)-trien-17-one, 3-(((9z)-1-oxo-9-octadecen-1-yl)oxy)-
180003-17-2
oleoylestrone
estrone monooleate
estrone oleic acid ester
DB04870
SCHEMBL38079
64R56KMG1Z ,
mp-101 (oleoylestrone)
DTXSID8041086
unii-64r56kmg1z
(8r,9s,13s,14s)-13-methyl-17-oxo-7,8,9,11,12,13,14,15,16,17-decahydro-6h-cyclopenta[a]phenanthren-3-yl oleate
AKOS040749066

Research Excerpts

[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (66)

TimeframeStudies, This Drug (%)All Drugs %
pre-19900 (0.00)18.7374
1990's14 (21.21)18.2507
2000's47 (71.21)29.6817
2010's5 (7.58)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 15.53

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be moderate demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index15.53 (24.57)
Research Supply Index4.22 (2.92)
Research Growth Index4.56 (4.65)
Search Engine Demand Index10.37 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (15.53)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews1 (1.49%)6.00%
Case Studies1 (1.49%)4.05%
Observational0 (0.00%)0.25%
Other65 (97.01%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Clinical Trials (2)

Trial Overview

TrialPhaseEnrollmentStudy TypeStart DateStatus
A Phase 2a Randomized, Double-Blind, Placebo Controlled, Parallel Group, Safety and Efficacy Study of Two 14 Day Cycles of Oral Doses of Oleoyl-Estrone (MP-101) in Obese Adult Subjects [NCT00449202]Phase 2100 participants Interventional2006-06-30Active, not recruiting
A Phase 2a Randomized, Double-Blind, Placebo Controlled, Parallel Group, Safety and Efficacy Study of Oleoyl-Estrone (MP-101) in Male Obese Adults. [NCT00449254]Phase 224 participants (Anticipated)Interventional2006-10-31Active, not recruiting
[information is prepared from clinicaltrials.gov, extracted Sep-2024]